Press Release
View printer-friendly version << Back
Omeros to Present at the 14th Annual Needham Healthcare Conference

SEATTLE, April 9, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 14th Annual Needham Healthcare Conference in New York next week.  The presentation is scheduled for Tuesday, April 14 at 10:40am EDT.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page under the Investors section of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. Derived from its proprietary PharmacoSurgery® platform, the company's first drug product, Omidria (phenylephrine and ketorolac injection) 1%/0.3%, has been approved by the FDA for use during cataract surgery or intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative ocular pain. Omidria is currently under review for marketing approval by the European Medicines Agency. Omeros has six clinical-stage development programs focused on: complement-related thrombotic microangiopathies; Huntington's disease, schizophrenia, and cognitive impairment; addictive and compulsive disorders; and preventing problems associated with surgical procedures. In addition, Omeros has a proprietary GPCR platform, which is making available an unprecedented number of new GPCR drug targets and corresponding compounds to the pharmaceutical industry for drug development.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/omeros-to-present-at-the-14th-annual-needham-healthcare-conference-300063825.html

SOURCE Omeros Corporation

Erin Cox, Omeros Corporation, Investor and Media Relations, 206.676.5036, ecox@omeros.com